These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29937730)

  • 1. Applying a Global Sensitivity Analysis Workflow to Improve the Computational Efficiencies in Physiologically-Based Pharmacokinetic Modeling.
    Hsieh NH; Reisfeld B; Bois FY; Chiu WA
    Front Pharmacol; 2018; 9():588. PubMed ID: 29937730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic Models.
    Liu D; Li L; Rostami-Hodjegan A; Bois FY; Jamei M
    AAPS J; 2020 Jul; 22(5):93. PubMed ID: 32681207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global Sensitivity Analysis of the Rodgers and Rowland Model for Prediction of Tissue: Plasma Partitioning Coefficients: Assessment of the Key Physiological and Physicochemical Factors That Determine Small-Molecule Tissue Distribution.
    Yau E; Olivares-Morales A; Gertz M; Parrott N; Darwich AS; Aarons L; Ogungbenro K
    AAPS J; 2020 Feb; 22(2):41. PubMed ID: 32016678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Important pharmacokinetic parameters for individualization of
    Hardiansyah D; Kletting P; Begum NJ; Eiber M; Beer AJ; Pawiro SA; Glatting G
    Med Phys; 2021 Feb; 48(2):556-568. PubMed ID: 33244792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.
    Zurlinden TJ; Reisfeld B
    Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):267-80. PubMed ID: 25636597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Methodology for Global Sensitivity Analysis of Activated Sludge Models: Case Study with Activated Sludge Model No. 3 (ASM3).
    Fortela DLB; Farmer K; Zappi A; Sharp WW; Revellame E; Gang D; Zappi M
    Water Environ Res; 2019 Sep; 91(9):865-876. PubMed ID: 31004529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Computational Workflow for Probabilistic Quantitative
    McNally K; Hogg A; Loizou G
    Front Pharmacol; 2018; 9():508. PubMed ID: 29867507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constraint-based perturbation analysis with cluster Newton method: a case study of personalized parameter estimations with irinotecan whole-body physiologically based pharmacokinetic model.
    Asami S; Kiga D; Konagaya A
    BMC Syst Biol; 2017 Dec; 11(Suppl 7):129. PubMed ID: 29322928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A latent variable approach to account for correlated inputs in global sensitivity analysis.
    Melillo N; Darwich AS
    J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):671-686. PubMed ID: 34032996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-compound and Intra-compound Global Sensitivity Analysis of a Physiological Model for Pulmonary Absorption of Inhaled Compounds.
    Melillo N; Grandoni S; Cesari N; Brogin G; Puccini P; Magni P
    AAPS J; 2020 Aug; 22(5):116. PubMed ID: 32862303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variance based global sensitivity analysis of physiologically based pharmacokinetic absorption models for BCS I-IV drugs.
    Melillo N; Aarons L; Magni P; Darwich AS
    J Pharmacokinet Pharmacodyn; 2019 Feb; 46(1):27-42. PubMed ID: 30552544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of global sensitivity analysis in the development of a physiologically based pharmacokinetic model for m-xylene and ethanol co-exposure in humans.
    Loizou GD; McNally K; Jones K; Cocker J
    Front Pharmacol; 2015; 6():135. PubMed ID: 26175688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A framework for 2-stage global sensitivity analysis of GastroPlus™ compartmental models.
    Scherholz ML; Forder J; Androulakis IP
    J Pharmacokinet Pharmacodyn; 2018 Apr; 45(2):309-327. PubMed ID: 29423863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying global sensitivity analysis to the modelling of flow and water quality in sewers.
    Gamerith V; Neumann MB; Muschalla D
    Water Res; 2013 Sep; 47(13):4600-11. PubMed ID: 23764609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian evaluation of a physiologically-based pharmacokinetic (PBPK) model of long-term kinetics of metal nanoparticles in rats.
    Sweeney LM; MacCalman L; Haber LT; Kuempel ED; Tran CL
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):151-63. PubMed ID: 26145831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification.
    Krauss M; Burghaus R; Lippert J; Niemi M; Neuvonen P; Schuppert A; Willmann S; Kuepfer L; Görlitz L
    In Silico Pharmacol; 2013; 1():6. PubMed ID: 25505651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pksensi: An R package to apply global sensitivity analysis in physiologically based kinetic modeling.
    Hsieh NH; Reisfeld B; Chiu WA
    SoftwareX; 2020; 12():. PubMed ID: 33426260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the potential of Morris algorithm for improving the computational constraints of global sensitivity analysis.
    Nabi S; Ahanger MA; Dar AQ
    Environ Sci Pollut Res Int; 2021 Nov; 28(43):60900-60912. PubMed ID: 34165749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pharmacokinetics and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach: A case study of caffeine and ciprofloxacin.
    Park MH; Shin SH; Byeon JJ; Lee GH; Yu BY; Shin YG
    Korean J Physiol Pharmacol; 2017 Jan; 21(1):107-115. PubMed ID: 28066147
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.